|
Last Updated: Nov 17th, 2006 - 22:35:04 |
Latest Research
:
Pharmacology
:
Anticholesterol
:
Simvastatin
Statin simvastatin linked to protection against endothelial dysfunction in diabetic rats
Almost two years ago, the diabetes arm of the Heart Protection Study, the largest-ever study using a cholesterol-lowering medication, found that diabetics who took a daily dose of the statin drug simvastatin over five years reduced the risk of a first nonlethal heart attack by 37 percent and risk of a first nonfatal or fatal stroke by 24 percent, regardless of their cholesterol or glucose levels. That is significant, since people with diabetes are two to four times more likely than others to have a coronary event even though their low-density lipid (LDL) cholesterol levels are similar to those in the general population.
Apr 3, 2005, 10:33
|
